CCM
AZN icon

Causeway Capital Management’s AstraZeneca AZN Stock Holding History

Causeway Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75B Buy
9,357,390
+1,935,641
+26% +$364M 18.97% 1
2026
Q1 		$1.44B Buy
7,421,749
+6,916,300
+1,368% +$1.33B 17.66% 1
2025
Q4 		$92.9M Sell
505,449
-28,237
-5% -$4.95M 1.28% 14
2025
Q3 		$81.9M Buy
533,686
+56,962
+12% +$8.62M 1.08% 16
2025
Q2 		$66.6M Buy
476,724
+47,780
+11% +$6.7M 1.05% 16
2025
Q1 		$63.1M Buy
428,944
+13,009
+3% +$1.88M 1.32% 18
2024
Q4 		$54.5M Buy
415,935
+170,715
+70% +$23.9M 1.24% 20
2024
Q3 		$38.2M Buy
245,220
+19,926
+9% +$3.22M 0.94% 33
2024
Q2 		$35.1M Sell
225,294
-22,944
-9% -$3.45M 0.96% 36
2024
Q1 		$33.6M Buy
248,238
+17,877
+8% +$2.37M 0.88% 36
2023
Q4 		$31M Buy
230,361
+52,750
+30% +$6.86M 0.79% 40
2023
Q3 		$24.1M Buy
177,611
+45,438
+34% +$6.21M 0.63% 42
2023
Q2 		$18.9M Sell
132,173
-29,679
-18% -$4.37M 0.5% 48
2023
Q1 		$22.5M Buy
161,852
+17,542
+12% +$2.36M 0.54% 36
2022
Q4 		$19.6M Sell
144,310
-7,997
-5% -$1M 0.57% 45
2022
Q3 		$16.7M Sell
152,307
-14,642
-9% -$1.86M 0.47% 49
2022
Q2 		$22.1M Sell
166,949
-37,129
-18% -$4.87M 0.55% 41
2022
Q1 		$27.1M Buy
204,078
+38,842
+24% +$4.66M 0.65% 39
2021
Q4 		$19.3M Sell
165,236
-8,270
-5% -$973K 0.42% 49
2021
Q3 		$20.8M Buy
173,506
+88,614
+104% +$10.3M 0.47% 49
2021
Q2 		$10.2M Buy
+84,892
New +$9.31M 0.21% 67

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Causeway Capital Management's AZN Position: Q2 2026 in Review

Causeway Capital Management increased its AstraZeneca (AZN) stake by 26% in Q2 2026, buying an estimated $364M and bringing the position to 9,357,390 shares worth $1.75B. The position accounts for 18.97% of the portfolio, ranked #1.

Causeway Capital Management first reported a position in AZN in Q2 2021 and has held it in 21 quarters since. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Causeway Capital Management held 9,357,390 shares of AstraZeneca worth $1.75B as of Q2 2026.
  • Causeway Capital Management bought 1,935,641 AstraZeneca shares in Q2 2026, an estimated $364M.
  • AstraZeneca made up 18.97% of Causeway Capital Management's portfolio in Q2 2026, its #1 holding.
  • Causeway Capital Management first reported a position in AstraZeneca in Q2 2021 and has held it in 21 quarters since.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Causeway Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.